Mild to Severe Neurological Manifestations of COVID-19: Cases Reports.
Gabriele MelegariVeronica RiviGabriele ZelentVincenzo NasilloElena De SantisAlessandra MelegariClaudia BevilacquaMichele ZoliStefano MelettiAlberto BarbieriPublished in: International journal of environmental research and public health (2021)
The main focus of Coronavirus disease 2019 (COVID-19) infection is pulmonary complications through virus-related neurological manifestations, ranging from mild to severe, such as encephalitis, cerebral thrombosis, neurocognitive (dementia-like) syndrome, and delirium. The hospital screening procedures for quickly recognizing neurological manifestations of COVID-19 are often complicated by other coexisting symptoms and can be obscured by the deep sedation procedures required for critically ill patients. Here, we present two different case-reports of COVID-19 patients, describing neurological complications, diagnostic imaging such as olfactory bulb damage (a mild and unclear underestimated complication) and a severe and sudden thrombotic stroke complicated with hemorrhage with a low-level cytokine storm and respiratory symptom resolution. We discuss the possible mechanisms of virus entrance, together with the causes of COVID-19-related encephalitis, olfactory bulb damage, ischemic stroke, and intracranial hemorrhage.
Keyphrases
- coronavirus disease
- sars cov
- cerebral ischemia
- respiratory syndrome coronavirus
- early onset
- atrial fibrillation
- drug induced
- case report
- oxidative stress
- risk factors
- subarachnoid hemorrhage
- pulmonary hypertension
- mild cognitive impairment
- high resolution
- healthcare
- brain injury
- bipolar disorder
- emergency department
- single molecule
- cognitive impairment
- acute kidney injury
- intensive care unit
- cerebral blood flow
- mass spectrometry
- acute respiratory distress syndrome
- patient reported
- electronic health record
- hip fracture